<DOC>
	<DOC>NCT00249678</DOC>
	<brief_summary>The purpose of this study is...to assess whether placing a substance abuse intervention for HIV+ methamphetamine users within an HIV medical care setting improves rates of follow-up on referral to treatment by primary care physicians; reduces drug use and sexual risk behaviors more than treatment-as-usual; and increases rates of adherence to HIV medication regimens.</brief_summary>
	<brief_title>Behavioral Therapy Development for Methamphetamine Abusers</brief_title>
	<detailed_description />
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>1. HIVseropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the UCLA CARE clinic, aged 1865 2. Willing to give informed consent and comply with study procedures; 3. Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications; 4. Diagnosed with current methamphetamine abuse as determined by MINI; and 5. Interested in seeking treatment for their methamphetamine abuse and in participating in this research project. 1. Unwilling to give, or withdrawal of, informed consent; 2. Inability to understand nature of study; 3. A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets DSMIVTR criteria for current bipolar disorder or a psychotic disorder); 4. Current suicidal ideation or suicide attempt within the past 3 months; and 5. Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI. 6. Total lack of any type of healthcare coverage. These potential participants will be given lowfee treatment referrals.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Behavior Therapy</keyword>
	<keyword>methamphetamine</keyword>
</DOC>